Newlight Partners LP Harmony Biosciences Holdings, Inc. Transaction History

Newlight Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$33.54 - $52.15 $21.8 Million - $34 Million	-651,221 Reduced 99.98%	151 $7,000
Q1 2022 May 12, 2022	SELL	$33.14 - $51.13 $8.27 Million - $12.8 Million	-249,452 Reduced 27.69%	651,372 $31.7 Million
Q4 2021 Feb 11, 2022	SELL	$34.09 - $43.91 $34.1 Million - $43.9 Million	-1,000,000 Reduced 52.61%	900,824 $38.4 Million
Q3 2021 Nov 15, 2021	SELL	$25.68 - $38.61 $19.7 Million - $29.6 Million	-765,632 Reduced 28.71%	1,900,824 $72.9 Million
Q2 2021 Aug 13, 2021	SELL	$25.96 - $33.44 $63,368 - $81,627	-2,441 Reduced 0.09%	2,666,456 $75.3 Million
Q3 2020 Nov 16, 2020	BUY	$30.96 - $44.39 $82.6 Million - $118 Million	2,668,897 New	2,668,897 $90.5 Million

254

46.6M

119K

50K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Newlight Partners LP, based on Form 13F filings with the SEC.

Stay updated on Newlight Partners LP with notifications on news.